Midazolam In 0.8% Sodium Chloride Injection, Solution
NDC Package 0264-8002-32

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Midazolam In 0.8% Sodium Chloride injection is a medication used by people with epilepsy to treat a certain type of serious seizure that doesn't stop (seizure clusters). This formulation utilizes a injection, solution delivery system. Marketed by B. Braun Medical Inc., this product is identified by NDC 0264-8002 and is authorized under FDA application ANDA218454.

Identification & Billing

NDC Package Code
0264-8002-32
Package Description
30 CONTAINER in 1 CASE / 100 mL in 1 CONTAINER
Product Code
0264-8002
11-Digit Billing Format
00264800232
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Midazolam In 0.8% Sodium Chloride
Non-Proprietary Name
Midazolam In 0.8% Sodium Chloride
Substance Name
Midazolam
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
MIDAZOLAM 1 mg/mL
Pharmacologic Class
Usage Information
This medication is used by people with epilepsy to treat a certain type of serious seizure that doesn't stop (seizure clusters). Midazolam belongs to a class of drugs known as benzodiazepines. It may work by increasing the effect of a certain substance in your body (GABA), which helps calm the brain and nerves.
DEA Schedule
Schedule IV (CIV) Substances

Regulatory & Marketing

Labeler Name
B. Braun Medical Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA218454
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-15-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0264-8002-32 identifies a specific commercial package of 30 container in 1 case / 100 ml in 1 container of Midazolam In 0.8% Sodium Chloride, a human prescription drug labeled by B. Braun Medical Inc.. This injection, solution is formulated for intravenous use and contains midazolam as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by B. Braun Medical Inc. on October 15, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used by people with epilepsy to treat a certain type of serious seizure that doesn't stop (seizure clusters). Midazolam belongs to a class of drugs known as benzodiazepines. It may work by increasing the effect of a certain substance in your body (GABA), which helps calm the brain and nerves.

How is this B. Braun Medical Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00264800232. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0264-8002-32
11-Digit CMS (5-4-2)
00264-8002-32

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.